Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949246 · ClinicalTrials.gov registry record
Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 221
- Enrollment target
NCT01949246: Completed study, sponsored by Massachusetts General Hospital.
NCT01949246 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 221 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01949246 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 221 participants
- Enrollment target
Study Summary
The prospective study aims: 1. To determine the role and mechanism of biomarkers for prediction of response to CRT 2. To determine the role of biomarkers and their effect on left ventricular remodeling in patients undergoing CRT.
Primary Outcome
death, HF hospitalization, left ventricular assist device, heart transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2007-09 |
| Est. Completion | 2016-01-01 |
What the finished NCT01949246 record still lists
NCT01949246 is an observational study that tracks outcomes without assigning an intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01949246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01949246 about?
NCT01949246 is a clinical study titled "Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)". The prospective study aims: 1. To determine the role and mechanism of biomarkers for prediction of response to CRT 2. To determine the role of biomarkers and their effect on left ventricular remodeling in patients undergoing CRT.
What is the current status of trial NCT01949246?
This trial is currently completed. The enrollment target is 221 participants. The study started on 2007-09. Estimated completion is 2016-01-01.
Who is sponsoring clinical trial NCT01949246?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03170440 · 221 participants · NA
Non-invasive Nerve Stimulation for PTSD and Sleep
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia